Ambulatory Cancer Pain Management: A Feasibility Study
The primary purpose of this study is to examine the feasibility of collecting pain and other symptom data in outpatient treatment centers across multiple institutions in the Texas Medical Center (TMC). We will also examine the prevalence and severity of cancer-related pain and begin to identify other commonly reported symptoms in outpatient settings. Factors that interfere with management of pain will also be examined. Additionally, the study will explore patient satisfaction with pain management and pain education in outpatient settings. The specific aims of this study include:
Primary Objective:
-Explore the feasibility of a collaborative effort by oncology nurses to collect pain and symptom data across multiple institutions that care for ambulatory cancer patients in the TMC.
Secondary Objectives:
- Describe the prevalence and severity of pain and other symptoms in persons with breast, colorectal, lung, or prostate cancer who are receiving chemotherapy in the outpatient setting.
- Describe factors that interfere with adequate pain management in these patients.
- Examine patient satisfaction with pain management and patient education about pain management.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
You will be asked to complete 3 questionnaires that will take a total of about 20 minutes to complete. Your name or medical record number will not appear on the questionnaires. You will be assigned a study subject code number. The study chair will keep a file that links your name to the code.
The first questionnaire will ask for basic demographic information (such as gender, ethnicity, and education) and your current chemotherapy and pain medications. If you cannot remember the names of these medications, researchers will locate them in your M. D. Anderson medical record.
The second questionnaire asks you to rate your pain and a variety of symptoms (for example, fatigue and nausea).
The last questionnaire includes 3 sections. The first section asks about your beliefs about pain and its treatment. The second part asks for your opinion about your pain management and about the education you have received about pain management. On the last page, you will be asked to use a picture of the outline of a body to show the researchers where you have pain.
Once you have completed these questionnaires, you will be considered off-study.
This is an investigational study. Up to 125 patients will take part in this study. Up to 35 will be enrolled at M. D. Anderson.
Studientyp
Einschreibung (Tatsächlich)
Kontakte und Standorte
Studienorte
-
-
Texas
-
Houston, Texas, Vereinigte Staaten, 77030
- U.T.M.D. Anderson Cancer Center
-
Houston, Texas, Vereinigte Staaten, 77030
- Memorial Hermann Hospital
-
Houston, Texas, Vereinigte Staaten, 77030
- Methodist Hospital
-
Houston, Texas, Vereinigte Staaten, 77030
- Michael E. DeBakey Veterans Administration Medical Center
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
- Diagnosis of breast, colorectal, lung, or prostate cancer (any histological type).
- Currently undergoing chemotherapy.
- Age 18 or older.
- Able to read, write, and speak English.
- Able to understand the purpose of this study.
- Must be a patient at one of the four participating institutions.
- Must be receiving the 2nd, 3rd, or 4th cycle of chemotherapy.
Exclusion Criteria:
- Receiving chemotherapy in preparation for a bone marrow or stem cell transplant
- Received a bone marrow or stem cell transplant
- Age 17 or younger
- Receiving weekly chemotherapy.
- Receiving hormonal therapy alone.
- Receiving radiation or chemoradiation.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Kohorten und Interventionen
Gruppe / Kohorte |
Intervention / Behandlung |
|---|---|
|
Cancer Pain Management
Patients receiving chemotherapy for breast, colon, lung, or prostate cancer.
|
3 questionnaires that will take 20 minutes total to complete.
Andere Namen:
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Zeitfenster |
|---|---|
|
Pain and symptom data across multiple institutions
Zeitfenster: Survey data collection taking 30 minutes, collecation accomplished at multiple sites over 3 years
|
Survey data collection taking 30 minutes, collecation accomplished at multiple sites over 3 years
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Anita Broxson, RN, M.D. Anderson Cancer Center
Publikationen und hilfreiche Links
Nützliche Links
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Erkrankungen des Verdauungssystems
- Neubildungen
- Urogenitale Neoplasmen
- Neubildungen nach Standort
- Schmerzen
- Neurologische Manifestationen
- Gastrointestinale Neubildungen
- Neoplasmen des Verdauungssystems
- Magen-Darm-Erkrankungen
- Genitale Neubildungen, männlich
- Prostataerkrankungen
- Darmerkrankungen
- Darmerkrankungen
- Darmtumoren
- Rektale Erkrankungen
- Prostataneoplasmen
- Kolorektale Neubildungen
- Krebsschmerz
Andere Studien-ID-Nummern
- 2005-0841
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .